Cargando…
Development and validation of a neural network for NAFLD diagnosis
Non-Alcoholic Fatty Liver Disease (NAFLD) affects about 20–30% of the adult population in developed countries and is an increasingly important cause of hepatocellular carcinoma. Liver ultrasound (US) is widely used as a noninvasive method to diagnose NAFLD. However, the intensive use of US is not co...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511336/ https://www.ncbi.nlm.nih.gov/pubmed/34642390 http://dx.doi.org/10.1038/s41598-021-99400-y |
_version_ | 1784582742473703424 |
---|---|
author | Sorino, Paolo Campanella, Angelo Bonfiglio, Caterina Mirizzi, Antonella Franco, Isabella Bianco, Antonella Caruso, Maria Gabriella Misciagna, Giovanni Aballay, Laura R. Buongiorno, Claudia Liuzzi, Rosalba Cisternino, Anna Maria Notarnicola, Maria Chiloiro, Marisa Fallucchi, Francesca Pascoschi, Giovanni Osella, Alberto Rubén |
author_facet | Sorino, Paolo Campanella, Angelo Bonfiglio, Caterina Mirizzi, Antonella Franco, Isabella Bianco, Antonella Caruso, Maria Gabriella Misciagna, Giovanni Aballay, Laura R. Buongiorno, Claudia Liuzzi, Rosalba Cisternino, Anna Maria Notarnicola, Maria Chiloiro, Marisa Fallucchi, Francesca Pascoschi, Giovanni Osella, Alberto Rubén |
author_sort | Sorino, Paolo |
collection | PubMed |
description | Non-Alcoholic Fatty Liver Disease (NAFLD) affects about 20–30% of the adult population in developed countries and is an increasingly important cause of hepatocellular carcinoma. Liver ultrasound (US) is widely used as a noninvasive method to diagnose NAFLD. However, the intensive use of US is not cost-effective and increases the burden on the healthcare system. Electronic medical records facilitate large-scale epidemiological studies and, existing NAFLD scores often require clinical and anthropometric parameters that may not be captured in those databases. Our goal was to develop and validate a simple Neural Network (NN)-based web app that could be used to predict NAFLD particularly its absence. The study included 2970 subjects; training and testing of the neural network using a train–test-split approach was done on 2869 of them. From another population consisting of 2301 subjects, a further 100 subjects were randomly extracted to test the web app. A search was made to find the best parameters for the NN and then this NN was exported for incorporation into a local web app. The percentage of accuracy, area under the ROC curve, confusion matrix, Positive (PPV) and Negative Predicted Value (NPV) values, precision, recall and f1-score were verified. After that, Explainability (XAI) was analyzed to understand the diagnostic reasoning of the NN. Finally, in the local web app, the specificity and sensitivity values were checked. The NN achieved a percentage of accuracy during testing of 77.0%, with an area under the ROC curve value of 0.82. Thus, in the web app the NN evidenced to achieve good results, with a specificity of 1.00 and sensitivity of 0.73. The described approach can be used to support NAFLD diagnosis, reducing healthcare costs. The NN-based web app is easy to apply and the required parameters are easily found in healthcare databases. |
format | Online Article Text |
id | pubmed-8511336 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-85113362021-10-14 Development and validation of a neural network for NAFLD diagnosis Sorino, Paolo Campanella, Angelo Bonfiglio, Caterina Mirizzi, Antonella Franco, Isabella Bianco, Antonella Caruso, Maria Gabriella Misciagna, Giovanni Aballay, Laura R. Buongiorno, Claudia Liuzzi, Rosalba Cisternino, Anna Maria Notarnicola, Maria Chiloiro, Marisa Fallucchi, Francesca Pascoschi, Giovanni Osella, Alberto Rubén Sci Rep Article Non-Alcoholic Fatty Liver Disease (NAFLD) affects about 20–30% of the adult population in developed countries and is an increasingly important cause of hepatocellular carcinoma. Liver ultrasound (US) is widely used as a noninvasive method to diagnose NAFLD. However, the intensive use of US is not cost-effective and increases the burden on the healthcare system. Electronic medical records facilitate large-scale epidemiological studies and, existing NAFLD scores often require clinical and anthropometric parameters that may not be captured in those databases. Our goal was to develop and validate a simple Neural Network (NN)-based web app that could be used to predict NAFLD particularly its absence. The study included 2970 subjects; training and testing of the neural network using a train–test-split approach was done on 2869 of them. From another population consisting of 2301 subjects, a further 100 subjects were randomly extracted to test the web app. A search was made to find the best parameters for the NN and then this NN was exported for incorporation into a local web app. The percentage of accuracy, area under the ROC curve, confusion matrix, Positive (PPV) and Negative Predicted Value (NPV) values, precision, recall and f1-score were verified. After that, Explainability (XAI) was analyzed to understand the diagnostic reasoning of the NN. Finally, in the local web app, the specificity and sensitivity values were checked. The NN achieved a percentage of accuracy during testing of 77.0%, with an area under the ROC curve value of 0.82. Thus, in the web app the NN evidenced to achieve good results, with a specificity of 1.00 and sensitivity of 0.73. The described approach can be used to support NAFLD diagnosis, reducing healthcare costs. The NN-based web app is easy to apply and the required parameters are easily found in healthcare databases. Nature Publishing Group UK 2021-10-12 /pmc/articles/PMC8511336/ /pubmed/34642390 http://dx.doi.org/10.1038/s41598-021-99400-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Sorino, Paolo Campanella, Angelo Bonfiglio, Caterina Mirizzi, Antonella Franco, Isabella Bianco, Antonella Caruso, Maria Gabriella Misciagna, Giovanni Aballay, Laura R. Buongiorno, Claudia Liuzzi, Rosalba Cisternino, Anna Maria Notarnicola, Maria Chiloiro, Marisa Fallucchi, Francesca Pascoschi, Giovanni Osella, Alberto Rubén Development and validation of a neural network for NAFLD diagnosis |
title | Development and validation of a neural network for NAFLD diagnosis |
title_full | Development and validation of a neural network for NAFLD diagnosis |
title_fullStr | Development and validation of a neural network for NAFLD diagnosis |
title_full_unstemmed | Development and validation of a neural network for NAFLD diagnosis |
title_short | Development and validation of a neural network for NAFLD diagnosis |
title_sort | development and validation of a neural network for nafld diagnosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511336/ https://www.ncbi.nlm.nih.gov/pubmed/34642390 http://dx.doi.org/10.1038/s41598-021-99400-y |
work_keys_str_mv | AT sorinopaolo developmentandvalidationofaneuralnetworkfornaflddiagnosis AT campanellaangelo developmentandvalidationofaneuralnetworkfornaflddiagnosis AT bonfigliocaterina developmentandvalidationofaneuralnetworkfornaflddiagnosis AT mirizziantonella developmentandvalidationofaneuralnetworkfornaflddiagnosis AT francoisabella developmentandvalidationofaneuralnetworkfornaflddiagnosis AT biancoantonella developmentandvalidationofaneuralnetworkfornaflddiagnosis AT carusomariagabriella developmentandvalidationofaneuralnetworkfornaflddiagnosis AT misciagnagiovanni developmentandvalidationofaneuralnetworkfornaflddiagnosis AT aballaylaurar developmentandvalidationofaneuralnetworkfornaflddiagnosis AT buongiornoclaudia developmentandvalidationofaneuralnetworkfornaflddiagnosis AT liuzzirosalba developmentandvalidationofaneuralnetworkfornaflddiagnosis AT cisterninoannamaria developmentandvalidationofaneuralnetworkfornaflddiagnosis AT notarnicolamaria developmentandvalidationofaneuralnetworkfornaflddiagnosis AT chiloiromarisa developmentandvalidationofaneuralnetworkfornaflddiagnosis AT fallucchifrancesca developmentandvalidationofaneuralnetworkfornaflddiagnosis AT pascoschigiovanni developmentandvalidationofaneuralnetworkfornaflddiagnosis AT osellaalbertoruben developmentandvalidationofaneuralnetworkfornaflddiagnosis |